Baidu
map

多种微量元素制剂临床应用专家共识

2018-03-14 中华医学会肠外肠内营养学分会 中华外科杂志,2018,56(3) :168-176.

微量元素是生物体内含量极少但必需的一些元素,是机体有效利用葡萄糖、脂肪供能及合成蛋白质的基础,是肠外营养支持方案的必要组成部分。欧洲、美国、澳大利亚的学术组织均提出肠外营养中应常规添加静脉用多种微量元素制剂,并先后发表了关于成人肠外营养多种微量元素日需要量的推荐建议。中华医学会肠外肠内营养学分会基于循证医学原则、参考国内外最新研究结果和共识指南意见,制定本共识,包括肠外营养微量元素补充的推荐剂量,

中文标题:

多种微量元素制剂临床应用专家共识

发布日期:

2018-03-14

简要介绍:

微量元素是生物体内含量极少但必需的一些元素,是机体有效利用葡萄糖、脂肪供能及合成蛋白质的基础,是肠外营养支持方案的必要组成部分。欧洲、美国、澳大利亚的学术组织均提出肠外营养中应常规添加静脉用多种微量元素制剂,并先后发表了关于成人肠外营养多种微量元素日需要量的推荐建议。中华医学会肠外肠内营养学分会基于循证医学原则、参考国内外最新研究结果和共识指南意见,制定本共识,包括肠外营养微量元素补充的推荐剂量,严重创伤和围手术期患者、危重症与中重度烧伤患者、肿瘤患者、肝病患者和儿科患者等接受肠外营养时应用微量元素的指导和建议。

 

拓展指南:微量元素相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (42)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2214832, encodeId=d084221483263, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdce9384791, createdName=ms7000001951413789, createdTime=Sun Jul 14 11:05:44 CST 2024, time=2024-07-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1059862, encodeId=c18a1059862da, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Tue Oct 12 16:23:10 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059574, encodeId=98e610595e481, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:13:30 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059573, encodeId=a57b10595e362, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:10:25 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806376, encodeId=4b9a8063e6d9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Wed Aug 05 18:38:18 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2024-07-14 ms7000001951413789 来自安徽省

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2214832, encodeId=d084221483263, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdce9384791, createdName=ms7000001951413789, createdTime=Sun Jul 14 11:05:44 CST 2024, time=2024-07-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1059862, encodeId=c18a1059862da, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Tue Oct 12 16:23:10 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059574, encodeId=98e610595e481, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:13:30 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059573, encodeId=a57b10595e362, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:10:25 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806376, encodeId=4b9a8063e6d9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Wed Aug 05 18:38:18 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2021-10-12 146a595fm25(暂无昵称)

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2214832, encodeId=d084221483263, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdce9384791, createdName=ms7000001951413789, createdTime=Sun Jul 14 11:05:44 CST 2024, time=2024-07-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1059862, encodeId=c18a1059862da, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Tue Oct 12 16:23:10 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059574, encodeId=98e610595e481, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:13:30 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059573, encodeId=a57b10595e362, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:10:25 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806376, encodeId=4b9a8063e6d9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Wed Aug 05 18:38:18 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2021-10-11 146a595fm25(暂无昵称)

    学习谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2214832, encodeId=d084221483263, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdce9384791, createdName=ms7000001951413789, createdTime=Sun Jul 14 11:05:44 CST 2024, time=2024-07-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1059862, encodeId=c18a1059862da, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Tue Oct 12 16:23:10 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059574, encodeId=98e610595e481, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:13:30 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059573, encodeId=a57b10595e362, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:10:25 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806376, encodeId=4b9a8063e6d9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Wed Aug 05 18:38:18 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2021-10-11 146a595fm25(暂无昵称)

    学习谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2214832, encodeId=d084221483263, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdce9384791, createdName=ms7000001951413789, createdTime=Sun Jul 14 11:05:44 CST 2024, time=2024-07-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1059862, encodeId=c18a1059862da, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Tue Oct 12 16:23:10 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059574, encodeId=98e610595e481, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:13:30 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059573, encodeId=a57b10595e362, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30b05155397, createdName=146a595fm25(暂无昵称), createdTime=Mon Oct 11 21:10:25 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806376, encodeId=4b9a8063e6d9, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/09cdac1bb7b7426a8dd112bd3fd2ad8e/541a6884f1d446a584b766afce6b510b.jpg, createdBy=88875409033, createdName=ms5000001342669861, createdTime=Wed Aug 05 18:38:18 CST 2020, time=2020-08-05, status=1, ipAttribution=)]
    2020-08-05 ms5000001342669861

    谢谢分享

    0

Baidu
map
Baidu
map
Baidu
map